Immunocore Holdings plc
IMCR
$28.38
-$1.67-5.54%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 4.74% | 6.43% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.74% | 6.43% | |||
| Cost of Revenue | -386.44% | -2.61% | |||
| Gross Profit | 701.70% | 27.53% | |||
| SG&A Expenses | 19.12% | -8.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.71% | -2.92% | |||
| Operating Income | 83.52% | 46.92% | |||
| Income Before Tax | -507.37% | 160.15% | |||
| Income Tax Expenses | 60.27% | -277.86% | |||
| Earnings from Continuing Operations | -372.10% | 175.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -372.10% | 175.21% | |||
| EBIT | 83.52% | 46.92% | |||
| EBITDA | 96.85% | 50.30% | |||
| EPS Basic | -372.05% | 175.16% | |||
| Normalized Basic EPS | -444.15% | 160.11% | |||
| EPS Diluted | -379.41% | 173.18% | |||
| Normalized Diluted EPS | -463.25% | 156.95% | |||
| Average Basic Shares Outstanding | 0.05% | 0.02% | |||
| Average Diluted Shares Outstanding | -5.23% | 5.59% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
